A group of 48 patients of differing age and sex, suffering from 3rd degree hemorrhoids with pulmonary, cardiac or renal disease, epilepsy or scleroderma, so that the traditional operation under general anaesthesia is contraindicated, is examined. Cryosurgical haemorrhoidectomy, without hospitalisation, under local anaesthesia of anal sphincter led in all these patients to cure verified rectoscopically 2-3 months after the operation. The postoperative course was entirely normal, with pain symptoms that were sharp in 7 cases, limited in 14. A serohematic secretion occurred for about a week in 6 patients. Normal living and working activity was resumed on average after about 11 days.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Targeted microwave ablation of localised prostate cancer: Initial results of VIOLETTE trial.
BJUI Compass
December 2024
Department of Urology, Jules Bordet Institute, Hôpital Universitaire de Bruxelles Université Libre de Bruxelles Brussels Belgium.
Objective: The aim of this study was to assess the precision and safety of targeted microwave ablation (TMA) using organ-based tracking (OBT) fusion, in patients with intermediate risk prostate cancer.
Patients And Method: We conducted a prospective, multicentric trial. Eligible patients had a prostate-specific antigen (PSA) < 20 ng/mL, a magnetic resonance imaging (MRI)-visible index tumour of Gleason score 3 + 4, with largest axis ≤15 mm and distant of at least 5 mm from the rectum and apex.
Transperineal 3D fusion imaging-guided targeted microwaves ablation for low to intermediate-risk prostate cancer: results of a phase I-II study.
Minim Invasive Ther Allied Technol
November 2024
Division of Urology, Department of Surgical Sciences, Molinette Hospital, University of Turin, Turin, Italy.
Article Synopsis
- Targeted microwave ablation (TMA) shows promise as a safe and effective treatment for localized prostate cancer, based on a pilot trial involving 11 patients.* -
- No severe complications were reported, and a significant percentage of patients exhibited no cancer in the treated area after follow-up, although new cancer foci were found in some cases.* -
- The study acknowledges limitations such as a small sample size, short follow-up duration, and absence of a comparison group, but supports the potential of TMA combined with fusion imaging for prostate cancer therapy.*
Robot-assisted extended rectal anterior resection for peritoneal dissemination of hepatocellular carcinoma invading rectum after atezolizumab plus bevacizumab combined therapy.
Int Cancer Conf J
October 2024
Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507 Japan.
Article Synopsis
- Patients with hepatocellular carcinoma (HCC) and extrahepatic metastasis generally have a poor prognosis, but combination therapy with atezolizumab and bevacizumab (ATZ/BEV) shows strong antitumor efficacy.
- A 74-year-old man with a history of HCC faced severe complications, including rectovesical pouch dissemination, but responded well to ATZ/BEV treatment despite needing to discontinue bevacizumab due to fistula formation.
- After a year of treatment, the tumors shrank significantly, allowing for curative robot-assisted surgery which confirmed the successful removal of the HCC with clear margins.
A case of recto-urethral fistula following MRI-guided transurethral ablation (TULSA) of the prostate.
Urol Case Rep
September 2024
Departments of Urology (X.M. and D.N.C) and Radiology (D.N.C), University of Texas Southwestern Medical Center, Dallas, TX, USA.
We describe the first case of a recto-urethral fistula following an MRI-guided transurethral prostate ablation procedure (TULSA). The patient experienced urine per rectum six weeks after the procedure. A voiding cystourethrogram confirmed the presence of a recto-urethral fistula, which was managed with a urethral catheter and a suprapubic tube.
View Article and Find Full Text PDFRadially Emitting Diode Laser Closure of Transsphincteric Fistula-in-Ano.
Dis Colon Rectum
September 2024
Department of Nursing, Mayo Clinic, Rochester, Minnesota.
Background: There has been a shift in the treatment of fistula-in-ano towards a focus on preservation of continence while simultaneously eradicating disease. Utilization of radially emitting diode laser catheters to ablate fistula tracks has been described since 2011 with heterogenous studies publishing success rates ranging from 20% to 89%.
Objective: Present our experience managing solitary transsphincteric fistulas of cryptoglandular origin with radially emitting diode laser.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!